Stock listing

OTC:PURE PURE Bioscience Stock

Follow PURE Bioscience into a list and get an email when it puts out news.

Share price · OTC:PURE

$0.055 USD -0.003 (-5.2%)

Close on Nov 20, 2026

Past year +10.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.045 – $0.055 USDNov 20, 2026
Volume
10,987 sharesNov 20, 2026
Market cap
$7.71M USDAt the close on Nov 20, 2026 · price × 140.2M shares outstanding
52-week range
$0.040 – $0.100 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1,675 USDMedian day 10,275 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
PURE Bioscience logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:PURE · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.055-0.003-5.2%$0.050$0.055$0.04510,987
$0.058-0.001-1.7%$0.058$0.058$0.0587,000
$0.059-0.001-1.7%$0.059$0.059$0.0593,451
$0.060-0.010-14.3%$0.060$0.060$0.0605,988
$0.0700.0000.0%$0.058$0.070$0.0587,800
$0.070+0.005+7.7%$0.070$0.070$0.070250
$0.065-0.005-7.1%$0.070$0.070$0.06514,000
$0.070+0.005+7.7%$0.070$0.070$0.0707,000
$0.0650.0000.0%$0.065$0.065$0.0652,622
$0.065+0.003+4.8%$0.057$0.065$0.05727,885
$0.062-0.003-4.6%$0.062$0.062$0.06220,500
$0.065-0.005-7.1%$0.070$0.070$0.06215,413
$0.070-0.002-2.8%$0.062$0.075$0.0627,700
$0.072-0.003-4.0%$0.070$0.072$0.06234,025
$0.0750.000-0.1%$0.071$0.075$0.06510,275
$0.075+0.002+2.7%$0.075$0.075$0.075275
$0.073-0.014-16.0%$0.073$0.075$0.07112,100
$0.0870.0000.0%$0.087$0.087$0.087225
$0.087-0.003-3.3%$0.087$0.087$0.0877,800
$0.090+0.010+12.5%$0.070$0.090$0.07022,500
$0.0800.0000.0%$0.070$0.090$0.07024,200
$0.080+0.010+14.3%$0.070$0.080$0.0701,900
$0.0700.0000.0%$0.070$0.080$0.07020,700
$0.070-0.010-12.5%$0.070$0.070$0.07025,200
$0.080+0.010+14.3%$0.080$0.080$0.0701,700
$0.0700.0000.0%$0.070$0.070$0.0703,600
$0.070-0.010-12.5%$0.070$0.080$0.0708,000
$0.0800.0000.0%$0.080$0.080$0.07034,500
$0.0800.0000.0%$0.080$0.080$0.0800
$0.0800.0000.0%$0.090$0.090$0.0808,200
$0.080-0.010-11.1%$0.090$0.090$0.0801,600
$0.090+0.010+12.5%$0.080$0.090$0.08018,000
$0.080+0.010+14.3%$0.070$0.090$0.060209,400
$0.070+0.010+16.7%$0.070$0.070$0.07060,600
$0.060-0.010-14.3%$0.060$0.070$0.06014,300
$0.0700.0000.0%$0.070$0.070$0.0706,500
$0.0700.0000.0%$0.070$0.070$0.07025
$0.070+0.010+16.7%$0.070$0.070$0.0701,500
$0.060-0.010-14.3%$0.060$0.070$0.060340,700
$0.070+0.010+16.7%$0.070$0.070$0.070400
$0.060-0.010-14.3%$0.060$0.060$0.060500
$0.070+0.010+16.7%$0.070$0.070$0.07020,200
$0.0600.0000.0%$0.070$0.070$0.06012,000
$0.060-0.010-14.3%$0.070$0.070$0.0604,100
$0.070-0.010-12.5%$0.070$0.070$0.0701,000
$0.080+0.010+14.3%$0.060$0.080$0.0603,700
$0.070-0.010-12.5%$0.060$0.080$0.06054,000
$0.080+0.010+14.3%$0.070$0.080$0.07021,200
$0.0700.0000.0%$0.070$0.070$0.0603,900
$0.0700.0000.0%$0.070$0.070$0.07014,300
$0.0700.0000.0%$0.080$0.080$0.0703,500
$0.070-0.010-12.5%$0.070$0.080$0.06026,100
$0.080+0.010+14.3%$0.060$0.080$0.06021,900
$0.0700.0000.0%$0.060$0.070$0.06011,000
$0.070+0.010+16.7%$0.060$0.070$0.05027,400
$0.060-0.020-25.0%$0.060$0.070$0.040145,400
$0.0800.0000.0%$0.060$0.080$0.06016,000
$0.080-0.010-11.1%$0.060$0.080$0.0602,200
$0.090+0.020+28.6%$0.090$0.090$0.0901,400
$0.070-0.010-12.5%$0.060$0.070$0.06033,000
$0.080+0.020+33.3%$0.090$0.090$0.08010,300
$0.0600.0000.0%$0.060$0.060$0.0604,860
$0.0600.0000.0%$0.090$0.090$0.06037,556
$0.0600.0000.0%$0.060$0.060$0.0600
$0.060-0.030-33.3%$0.090$0.090$0.060123,100

Splits

2 splits since 2000 · OTC:PURE · every price before a split is adjusted for it

DayRatioWhat
1-for-8Consolidation
51-for-50Split
Ticker
OTC:PURE
Asset type
Stock
Sector
Chemicals & materials
Industry
Chemicals
Exchange
OTC
Currency
USD

What changed lately

Latest news

All PURE Bioscience news

PURE Bioscience on 6ix

Sector
Chemicals & materials
Industry
Chemicals
News releases
4 in the last 12 months · 172 in all · newest Oct 29, 2026 · oldest 2013

Valuation

EV/sales 5.9× against a median of 0.5×: the highest of 10 Chemicals companies shown. Statements: Year to Jul 31, 2026 · price Nov 20, 2026

Enterprise value
$13.74M USD
P/E
Loss
EV/sales
5.9×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
57.3%
Operating margin
−90.0%
Net margin
−107.3%
Debt to equity
Negative equity
Beta vs S&P 500
0.09

Chemicals: the 10 companies nearest in size, of 628 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PURE Bioscience · OTC:PUREUS$7.71MUS$13.74Mn/a5.9×n/an/a−107.3%n/a0.09
PT Intanwijaya Internasional Tbk · IDX:INCIUS$9.15MUS$150,368n/an/an/a0.4×n/a0.0×n/a
Thai Poly Acrylic Public Co. Ltd. · SET:TPAUS$9.02MUS$5.88M50.9×0.4×15.0×0.8×1.2%0.0×n/a
B.I.G. Industries Bhd. · MYX:BIGUS$8.96MUS$2.80M9.8×0.3×0.9×0.7×9.5%0.1×n/a
UBIS (Asia) PCL · SET:UBISUS$8.81MUS$12.46M5.7×0.5×5.5×0.4×5.6%0.4×n/a
Alkali Metals Ltd. · NSE:ALKALIUS$8.40MUS$10.48M30.5×1.0×14.3×1.8×2.6%0.5×n/a
Vineet Laboratories Ltd. · NSE:VINEETLABUS$8.30MUS$11.31M22.0×1.7×10.1×1.7×5.6%1.0×n/a
OrganoClick AB · OMXSTO:ORGCUS$7.88MUS$15.52Mn/a1.8×n/a7.7×−35.7%7.5×n/a
Tribox Group AB Class B · OMXSTO:TRIBO_BUS$7.47MUS$8.01M53.7×0.5×7.5×1.6×0.9%0.5×n/a
TOR Minerals International, Inc. · OTC:TORMUS$6.55MUS$4.11Mn/a0.2×3.8×0.4×−2.1%0.1×0.61
Encres Dubuit SA · EURONEXT:ALDUBUS$6.10MUS$3.80Mn/a0.1×3.0×0.4×−9.6%0.1×n/a
Median of the othersUS$8.35MUS$6.94M26.3×0.5×6.5×0.8×1.2%0.3×0.61

Team and board

Officers

OfficerRole
Robert BartlettCEO
Jeff KitchellPresident,
James L. MarsdenExecutive Leader

Board

DirectorRole
Ivan ChenChairman of the Board
Bernard BlotnerBoard Member
Darin ZehrBoard Member
David M. RendallBoard Member
Robert BartlettCEO
Tom MyersBoard Member
Tom Y. LeeBoard Member

Events

QuarterResultsShare move
Q3 2026Jun 16, 20260.0%
Q2 2026Mar 18, 20260.0%
Q1 2026Dec 15, 20250.0%
Q4 2025Oct 29, 2025−12.5%
Q3 2025Jun 12, 2025 · Before open0.0%
Q2 2025Mar 17, 2025 · Before open0.0%
Q1 2025Dec 12, 2024 · Before open−14.3%
Q4 2024Oct 29, 2024 · After close0.0%
Q3 2024Jun 14, 2024 · After close+7.0%
Q2 2024Mar 18, 2024 · After close0.0%
All 20 quarters
QuarterResultsShare move
Q1 2024Dec 14, 2023 · After close−6.3%
Q4 2023Oct 30, 2023 · After close−20.0%
Q3 2023Jun 14, 2023 · After close−30.8%
Q2 2023Mar 17, 2023 · After close−18.8%
Q1 2023Dec 14, 2022 · After close−7.1%
Q4 2022Oct 28, 2022 · After close−10.5%
Q3 2022Jun 14, 2022 · After close−9.5%
Q2 2022Mar 15, 2022 · After close0.0%
Q1 2022Dec 15, 2021 · After close−14.8%
Quarter to Jul 31, 2021Oct 28, 2021 · After close0.0%

Open Events

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue2.31M2.20M1.96M1.87M1.81M3.70M6.92M1.91M1.77M1.83M
Cost of revenue992.0K899.0K811.0K906.0K853.0K1.85M2.90M728.0K763.0K760.0K
Gross profit1.33M1.30M1.15M971.0K1.00M2.08M4.02M1.18M1.01M1.07M
Research and development332.0K316.0K302.0K297.0K319.0K339.0K322.0K354.0K459.0K779.0K
Selling, general and administrative3.08M3.26M3.98M4.30M4.05M4.05M3.69M6.42M5.24M5.23M
Operating income-2.08M-2.27M-3.19M-3.94M-3.72M-2.31M4.00K-5.59M-7.04M-6.01M
Depreciation and amortization3.00K2.00K148.0K117.0K213.0K172.0K192.0K241.0K285.0K276.0K
EBITDA-2.08M-2.27M-3.04M-3.83M-3.51M-2.14M196.0K-5.35M-6.76M-5.73M
Interest expense407.0K299.0K155.0K14.0K6.00K4.00K5.00K6.00K8.00K
Income tax00001.65K1.65K1.65K1.65K1.65K1.65K
Net income-2.48M-2.40M-3.35M-3.96M-3.49M-2.32M4.00K-6.55M-7.44M-6.26M
Earnings per share, basic-0.02-0.02-0.03-0.04-0.04-0.030.00-0.09-0.11-0.10
Earnings per share, diluted-0.02-0.02-0.03-0.04-0.04-0.030.00-0.09-0.11-0.10

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents569.0K334.0K349.0K1.09M3.39M2.39M3.84M398.0K851.0K1.64M
Receivables334.0K474.0K298.0K285.0K201.0K368.0K1.09M373.0K275.0K297.0K
Inventory193.0K141.0K56.0K88.0K179.0K332.0K547.0K177.0K197.0K273.0K
Current assets1.19M1.05M805.0K1.60M3.86M3.20M5.57M1.04M1.46M2.46M
Property, plant and equipment8.00K11.0K13.0K221.0K620.0K740.0K316.0K362.0K461.0K548.0K
Total assets1.19M1.06M818.0K1.82M4.48M4.30M6.32M1.93M2.58M3.83M
Accounts payable820.0K784.0K601.0K422.0K488.0K593.0K1.34M553.0K608.0K426.0K
Current liabilities4.37M2.11M733.0K532.0K575.0K970.0K1.51M738.0K1.28M2.53M
Total debt6.60M
Total liabilities7.59M6.17M3.68M1.55M575.0K970.0K1.51M742.0K1.29M2.54M
Shareholders' equity-6.40M-5.12M-2.86M272.0K3.91M3.33M4.81M1.19M1.28M1.29M
Shares outstanding130.0M111.9M111.9M111.9M111.4M87.2M87.1M76.7M68.2M63.1M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-1.74M-2.02M-2.53M-3.28M-2.42M-1.17M669.0K-2.99M-3.89M-4.56M
Capital spending-33.0K-81.0K-521.0K-58.0K-7.00K-19.0K-206.0K
Free cash flow-3.31M-2.50M-1.69M611.0K-3.00M-3.91M-4.77M
Cash from investing-33.0K-81.0K-521.0K-58.0K-13.0K-34.0K-226.0K
Cash from financing1.97M2.00M1.78M1.01M3.50M239.0K2.83M2.55M3.13M1.23M
Change in cash235.0K-15.0K-746.0K-2.30M1.00M-1.45M3.44M-453.0K-789.0K-3.55M

Open Financials

Filings

FilingDateTypeFiled with
10-K · Annual reportOct 29, 2026Annual reportSEC
8-K · Current reportOct 29, 2026ResultsSEC
8-K · Current reportOct 20, 2026Material contractSEC
10-Q · Quarterly reportJun 15, 2026Quarterly reportSEC
8-K · Current reportJun 15, 2026ResultsSEC
8-K · Current reportMay 5, 2026Material contractSEC
10-Q · Quarterly reportMar 16, 2026Quarterly reportSEC
8-K · Current reportMar 16, 2026ResultsSEC
8-K · Current reportFeb 20, 2026Meeting outcomeSEC
DEF 14A · Proxy statementDec 30, 2025Meeting noticeSEC
Show 200 filings
FilingDateTypeFiled with
PRE 14A · Preliminary proxy statementDec 18, 2025Meeting noticeSEC
10-Q · Quarterly reportDec 15, 2025Quarterly reportSEC
8-K · Current reportDec 15, 2025ResultsSEC
3 · Initial statement of ownershipNov 28, 2025Insider tradeSEC
8-K · Current reportNov 19, 2025Management or board changeSEC
10-K · Annual reportOct 29, 2025Annual reportSEC
8-K · Current reportOct 29, 2025ResultsSEC
10-Q · Quarterly reportJun 16, 2025Quarterly reportSEC
8-K · Current reportJun 16, 2025ResultsSEC
10-Q · Quarterly reportMar 17, 2025Quarterly reportSEC
8-K · Current reportMar 17, 2025ResultsSEC
8-K · Current reportJan 28, 2025Meeting outcomeSEC
10-Q · Quarterly reportDec 16, 2024Quarterly reportSEC
8-K · Current reportDec 16, 2024ResultsSEC
DEF 14A · Proxy statementDec 12, 2024Meeting noticeSEC
10-K · Annual reportOct 29, 2024Annual reportSEC
8-K · Current reportOct 29, 2024ResultsSEC
8-K · Current reportSep 20, 2024Material contractSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
S-8 · Registration statement for employee plansAug 15, 2024Offer documentSEC
8-K · Current reportAug 9, 2024Current reportSEC
10-Q · Quarterly reportJun 14, 2024Quarterly reportSEC
8-K · Current reportJun 14, 2024ResultsSEC
3 · Initial statement of ownershipMay 13, 2024Insider tradeSEC
8-K · Current reportMay 7, 2024Management or board changeSEC
8-K · Current reportMar 27, 2024Material contractSEC
10-Q · Quarterly reportMar 18, 2024Quarterly reportSEC
8-K · Current reportMar 18, 2024ResultsSEC
8-K · Current reportFeb 26, 2024Meeting outcomeSEC
DEF 14A · Proxy statementJan 10, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementDec 19, 2023Meeting noticeSEC
10-Q · Quarterly reportDec 14, 2023Quarterly reportSEC
8-K · Current reportDec 14, 2023ResultsSEC
10-K · Annual reportOct 30, 2023Annual reportSEC
8-K · Current reportOct 30, 2023ResultsSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
4 · Change in ownershipAug 3, 2023Insider tradeSEC
8-K · Current reportJul 10, 2023Material contractSEC
10-Q · Quarterly reportJun 14, 2023Quarterly reportSEC
8-K · Current reportJun 14, 2023ResultsSEC
4 · Change in ownershipMar 22, 2023Insider tradeSEC
4 · Change in ownershipMar 22, 2023Insider tradeSEC
8-K · Current reportMar 21, 2023Management or board changeSEC
10-Q · Quarterly reportMar 17, 2023Quarterly reportSEC
8-K · Current reportMar 17, 2023ResultsSEC
3 · Initial statement of ownershipFeb 22, 2023Insider tradeSEC
3 · Initial statement of ownershipFeb 21, 2023Insider tradeSEC
8-K · Current reportFeb 10, 2023Meeting outcomeSEC
DEF 14A · Proxy statementDec 23, 2022Meeting noticeSEC
4 · Change in ownershipDec 19, 2022Insider tradeSEC
10-Q · Quarterly reportDec 14, 2022Quarterly reportSEC
8-K · Current reportDec 14, 2022ResultsSEC
10-K · Annual reportOct 28, 2022Annual reportSEC
8-K · Current reportOct 28, 2022ResultsSEC
4 · Change in ownershipOct 4, 2022Insider tradeSEC
4 · Change in ownershipOct 4, 2022Insider tradeSEC
4 · Change in ownershipOct 4, 2022Insider tradeSEC
4 · Change in ownershipOct 4, 2022Insider tradeSEC
4 · Change in ownershipOct 4, 2022Insider tradeSEC
4 · Change in ownershipOct 4, 2022Insider tradeSEC
4 · Change in ownershipJul 19, 2022Insider tradeSEC
4 · Change in ownershipJul 19, 2022Insider tradeSEC
4 · Change in ownershipJul 19, 2022Insider tradeSEC
8-K · Current reportJul 19, 2022Material contractSEC
10-Q · Quarterly reportJun 14, 2022Quarterly reportSEC
8-K · Current reportJun 14, 2022ResultsSEC
4 · Change in ownershipMar 22, 2022Insider tradeSEC
10-Q · Quarterly reportMar 15, 2022Quarterly reportSEC
8-K · Current reportMar 15, 2022ResultsSEC
8-K · Current reportFeb 8, 2022Meeting outcomeSEC
S-8 · Registration statement for employee plansJan 26, 2022Offer documentSEC
DEF 14A · Proxy statementDec 20, 2021Meeting noticeSEC
10-Q · Quarterly reportDec 15, 2021Quarterly reportSEC
8-K · Current reportDec 15, 2021ResultsSEC
10-K · Annual reportOct 28, 2021Annual reportSEC
8-K · Current reportOct 28, 2021ResultsSEC
8-K · Current reportAug 23, 2021Current reportSEC
4 · Change in ownershipJun 24, 2021Insider tradeSEC
3 · Initial statement of ownershipJun 24, 2021Insider tradeSEC
4 · Change in ownershipJun 22, 2021Insider tradeSEC
4 · Change in ownershipJun 22, 2021Insider tradeSEC
4 · Change in ownershipJun 22, 2021Insider tradeSEC
4 · Change in ownershipJun 22, 2021Insider tradeSEC
4 · Change in ownershipJun 22, 2021Insider tradeSEC
3 · Initial statement of ownershipJun 22, 2021Insider tradeSEC
10-Q · Quarterly reportJun 15, 2021Quarterly reportSEC
8-K · Current reportJun 15, 2021ResultsSEC
8-K · Current reportMay 19, 2021Current reportSEC
10-Q · Quarterly reportMar 15, 2021Quarterly reportSEC
8-K · Current reportMar 15, 2021ResultsSEC
8-K · Current reportJan 27, 2021Meeting outcomeSEC
4 · Change in ownershipDec 28, 2020Insider tradeSEC
10-Q · Quarterly reportDec 15, 2020Quarterly reportSEC
8-K · Current reportDec 15, 2020ResultsSEC
DEF 14A · Proxy statementDec 8, 2020Meeting noticeSEC
PRE 14A · Preliminary proxy statementNov 20, 2020Meeting noticeSEC
EFFECT · Notice that a registration is effectiveOct 26, 2020Other filingsSEC
POS AM · Amendment to an effective registrationOct 19, 2020Offer documentSEC
10-K · Annual reportOct 8, 2020Annual reportSEC
8-K · Current reportOct 8, 2020ResultsSEC
4 · Change in ownershipJun 26, 2020Insider tradeSEC
4 · Change in ownershipJun 22, 2020Insider tradeSEC
4 · Change in ownershipJun 22, 2020Insider tradeSEC
4 · Change in ownershipJun 18, 2020Insider tradeSEC
424B3 · ProspectusJun 15, 2020Offer documentSEC
10-Q · Quarterly reportJun 11, 2020Quarterly reportSEC
8-K · Current reportJun 11, 2020ResultsSEC
8-K · Current reportMay 21, 2020Material contractSEC
4 · Change in ownershipMay 19, 2020Insider tradeSEC
4 · Change in ownershipMay 19, 2020Insider tradeSEC
4 · Change in ownershipMay 19, 2020Insider tradeSEC
4 · Change in ownershipMay 19, 2020Insider tradeSEC
4 · Change in ownershipMay 19, 2020Insider tradeSEC
424B3 · ProspectusMar 13, 2020Offer documentSEC
4 · Change in ownershipMar 12, 2020Insider tradeSEC
4 · Change in ownershipMar 12, 2020Insider tradeSEC
4 · Change in ownershipMar 12, 2020Insider tradeSEC
10-Q · Quarterly reportMar 12, 2020Quarterly reportSEC
8-K · Current reportMar 12, 2020ResultsSEC
4 · Change in ownershipFeb 10, 2020Insider tradeSEC
4 · Change in ownershipFeb 10, 2020Insider tradeSEC
4/A · Change in ownership, amendedFeb 6, 2020Insider tradeSEC
4/A · Change in ownership, amendedFeb 6, 2020Insider tradeSEC
8-K · Current reportFeb 4, 2020Meeting outcomeSEC
4 · Change in ownershipJan 31, 2020Insider tradeSEC
4 · Change in ownershipJan 31, 2020Insider tradeSEC
4 · Change in ownershipJan 31, 2020Insider tradeSEC
DEF 14A · Proxy statementDec 19, 2019Meeting noticeSEC
424B3 · ProspectusDec 17, 2019Offer documentSEC
10-Q · Quarterly reportDec 13, 2019Quarterly reportSEC
8-K · Current reportDec 13, 2019ResultsSEC
8-K · Current reportNov 20, 2019Current reportSEC
EFFECT · Notice that a registration is effectiveNov 5, 2019Other filingsSEC
POS AM · Amendment to an effective registrationOct 31, 2019Offer documentSEC
10-K · Annual reportOct 29, 2019Annual reportSEC
8-K · Current reportOct 29, 2019ResultsSEC
4 · Change in ownershipOct 3, 2019Insider tradeSEC
4 · Change in ownershipOct 3, 2019Insider tradeSEC
4 · Change in ownershipOct 3, 2019Insider tradeSEC
8-K · Current reportOct 3, 2019Material contractSEC
5 · Annual statement of ownershipAug 6, 2019Insider tradeSEC
8-K · Current reportAug 2, 2019Material contractSEC
8-K · Current reportJul 31, 2019Management or board changeSEC
8-K · Current reportJul 19, 2019Material contractSEC
8-K · Current reportJul 12, 2019Management or board changeSEC
8-K · Current reportJun 26, 2019Material contractSEC
4/A · Change in ownership, amendedJun 25, 2019Insider tradeSEC
4/A · Change in ownership, amendedJun 25, 2019Insider tradeSEC
8-K · Current reportJun 25, 2019Material contractSEC
424B3 · ProspectusJun 14, 2019Offer documentSEC
10-Q · Quarterly reportJun 13, 2019Quarterly reportSEC
8-K · Current reportJun 13, 2019ResultsSEC
4 · Change in ownershipMay 13, 2019Insider tradeSEC
4 · Change in ownershipMay 13, 2019Insider tradeSEC
8-K · Current reportMay 13, 2019Material contractSEC
4 · Change in ownershipMar 7, 2019Insider tradeSEC
424B3 · ProspectusMar 7, 2019Offer documentSEC
10-Q · Quarterly reportMar 6, 2019Quarterly reportSEC
8-K · Current reportMar 6, 2019ResultsSEC
8-K · Current reportFeb 21, 2019Material contractSEC
4 · Change in ownershipFeb 21, 2019Insider tradeSEC
4 · Change in ownershipFeb 21, 2019Insider tradeSEC
3 · Initial statement of ownershipFeb 6, 2019Insider tradeSEC
8-K · Current reportFeb 1, 2019Management or board changeSEC
DEF 14A · Proxy statementDec 20, 2018Meeting noticeSEC
424B3 · ProspectusDec 14, 2018Offer documentSEC
10-Q · Quarterly reportDec 13, 2018Quarterly reportSEC
8-K · Current reportDec 13, 2018ResultsSEC
424B3 · ProspectusNov 13, 2018Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 1, 2018Other filingsSEC
POS AM · Amendment to an effective registrationOct 25, 2018Offer documentSEC
10-K · Annual reportOct 25, 2018Annual reportSEC
8-K · Current reportOct 25, 2018ResultsSEC
3 · Initial statement of ownershipOct 12, 2018Insider tradeSEC
8-K · Current reportOct 9, 2018Management or board changeSEC
8-K · Current reportSep 7, 2018Management or board changeSEC
4 · Change in ownershipAug 20, 2018Insider tradeSEC
8-K · Current reportAug 16, 2018Material contractSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from PURE Bioscience’s releases · as of Oct 29, 2026

Common shares
140,201,055
Fully diluted
140,201,055

Fully diluted

LineSharesAs of
Common shares140,201,055Oct 29, 2026

Share count over time

CountShares
Oct 29, 2026140,201,055

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Craig Johnson
Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 7, 2024); Heron Therapeutics, Inc. (Lead Independent Director · Since at least Jan 10, 2014); La Jolla Pharmaceutical Co (Director · Oct 14, 2013 – Aug 22, 2022 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past); Ardea Biosciences Inc (Director · Jan 3, 2011 – Jun 19, 2012 · Past)
Chief Financial Officer · Aug 1, 2011 – Aug 1, 2011 · Past
Peter C. Wulff
Other companies: GlucoTrack, Inc. (Chief Financial Officer · Jan 28, 2025 – Nov 5, 2026 · Past); Alphatec Holdings, Inc. (CFO, VP and Treasurer · Jun 16, 2008 – Aug 10, 2010 · Past)
CFO, COO & Secretary · Nov 5, 2012 – Oct 23, 2013 · Past
Gregory Hurd Barnhill
Other companies: Osiris Therapeutics Inc (Director · Aug 3, 2006 – Mar 23, 2012 · Past)
Director · Apr 12, 2006 – Jul 31, 2012 · Past
Janet Risi Field
Other companies: Onterris, Inc. (Director · Since at least Oct 19, 2021)
Director · Jul 27, 2017 – Feb 26, 2018 · Past
Kristin Taylor
Other companies: ImageWare Systems Incorporated (PRESIDENT & CEO · Apr 16, 2021 – Apr 16, 2021 · Past)
Director · Jan 20, 2021 – Sep 30, 2022 · Past
Bernard BlotnerBoard Member · Since at least Feb 8, 2023
Darin ZehrBoard Member · Since at least Nov 5, 2026
David M. RendallBoard Member · Since at least Jan 20, 2021
Dennis BrovaroneDirector · Oct 16, 2008 – Jul 31, 2012 · Past
Donna SingerVice President/Asst Secretary, Director · May 6, 2010 – Jan 24, 2013 · Past
All 23 people
PersonSeat
Gary BrownellDirector · Apr 12, 2006 – Feb 14, 2008 · Past
Gary CoheeDirector · Aug 13, 2013 – Feb 26, 2018 · Past
Ivan ChenChairman of the Board · Since at least Jun 28, 2018
Jeff KitchellPresident, · Since at least Nov 19, 2025
Jeffrey Scott KitchellPresident, Corporate Secretary · Since at least Nov 17, 2025
John J CarboneDirector · Mar 3, 2009 – Jul 31, 2012 · Past
Mark Stuart ElliottVice President, Finance · Jul 31, 2015 – Aug 20, 2024 · Past
Michael L KrallChief Executive Officer, Director · Jan 24, 2013 – Jan 24, 2013 · Past
Robert BartlettCEO · Since at least Feb 8, 2023
Tim SteffensmeierVice President of Sales · Jun 2, 2025 – Nov 4, 2026 · Past
Tom MyersBoard Member · Since at least Oct 4, 2018
Tom Y. LeeBoard Member · Since at least Jul 15, 2022
William OtisDirector · Oct 8, 2013 – Feb 26, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about PURE Bioscience.